Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01792024 · ClinicalTrials.gov registry record · NA
MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer
A NA study of Stage I Prostate Cancer and Stage II Prostate Carcinoma, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT01792024 is a NA study of Stage I Prostate Cancer and Stage II Prostate Carcinoma that has completed, run by University of Chicago. The registered enrollment target is 27 participants, below the 57-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01792024, a NA study of Stage I Prostate Cancer and Stage II Prostate Carcinoma, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase II trial studies how well magnetic resonance (MR)-guided laser interstitial thermal therapy works in treating patients with prostate cancer. Laser therapy uses intense, narrow beams of light to cut and destroy tissue and may help treat prostate cancer
Conditions Studied
Interventions
- PROCEDURE magnetic resonance imaging
- DEVICE Visualase Thermal Therapy
Study Locations (1)
Illinois
- University of Chicago Comprehensive Cancer Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2013-01-28 |
| Est. Completion | 2015-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01792024
The ClinicalTrials.gov registry entry for NCT01792024 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 57-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target (53% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stage I Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which magnetic resonance imaging is the first listed.
NCT01792024 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01792024 about?
NCT01792024 is a clinical study titled "MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer". This phase II trial studies how well magnetic resonance (MR)-guided laser interstitial thermal therapy works in treating patients with prostate cancer. Laser therapy uses intense, narrow beams of light to cut and destroy tissue and may help treat prostate cancer
What is the current status of trial NCT01792024?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2013-01-28. Estimated completion is 2015-09-16.
What conditions does trial NCT01792024 study?
This clinical trial studies the following conditions: Stage I Prostate Cancer, Stage II Prostate Carcinoma.
What interventions are being tested in trial NCT01792024?
The interventions under investigation include: magnetic resonance imaging (PROCEDURE), Visualase Thermal Therapy (DEVICE).
Who is sponsoring clinical trial NCT01792024?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01792024 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage I Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
RECRUITING · NA
-
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Researching the Effect of Exercise on Cancer
ACTIVE NOT RECRUITING · NA
-
Visually Enhanced Education About Prostate Cancer
COMPLETED · NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.